TF
Tiago Fauth Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.2%
Neutral
23.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $217 |
109%
upside
| 5 | +12% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $18 |
218%
upside
| 2 | +27% |
0
%
| 4 Sep ‘25 9 months ago |
|
|
|
Equal-Weight
Maintained
| $414 |
24%
downside
| 3 | – |
–
| 3 Sep ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $10 |
194%
upside
| 1 | -52% |
0
%
| 3 Sep ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $73 |
7%
upside
| 4 | +11% |
0
%
| 20 Aug ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $31 |
44%
downside
| 3 | +36% |
0
%
| 13 Aug ‘25 9 months ago |
|
|
|
Equal-Weight
Maintained
| $395 |
36%
upside
| 3 | – |
–
| 1 Aug ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $65 |
191%
upside
| 1 | -47% |
0
%
| 10 Jul ‘25 10 months ago |
|
|
|
Equal-Weight
Downgraded
| $107 |
0%
upside
| 3 | +20% |
0
%
| 10 Jul ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $76 |
17%
upside
| 1 | +58% |
0
%
| 30 Jun ‘25 11 months ago |
|